BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dabbous H, Sakr M, Abdelhakam S, Montasser I, Bahaa M, Said H, El-Meteini M. Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol 2016; 8(22): 942-948 [PMID: 27574548 DOI: 10.4254/wjh.v8.i22.942]
URL: https://www.wjgnet.com/1948-5182/full/v8/i22/942.htm
Number Citing Articles
Kumar Jayant, Thomas G. Cotter, Isabella Reccia, Francesco Virdis, Mauro Podda, Nikolaos Machairas, Ramesh P. Arasaradnam, Diego di Sabato, John C. LaMattina, Rolf N. Barth, Piotr Witkowski, John J. Fung. Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHALICE Study)Journal of Clinical Medicine 2023; 12(18): 5795 doi: 10.3390/jcm12185795
Ahmad Anouti, Madhukar S. Patel, Lisa B. VanWagner, William M. Lee, Sumeet K. Asrani, Arjmand R. Mufti, Nicole E. Rich, Parsia A. Vagefi, Jigesh A. Shah, Thomas A. Kerr, Mark Pedersen, Steven Hanish, Amit G. Singal, Thomas G. Cotter. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USALiver Transplantation 2023;  doi: 10.1097/LVT.0000000000000228
Garrett R. Roll, Michael Spiro, Dimitri Aristotle Raptis, Arif Jalal, Cheung Tsz Yan, Kim M. Olthoff, Juan C. Caicedo, Kwang‐Woong Lee, Shintaro Yagi, Mark S. Cattral, Arvinder S. Soin. Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendationsClinical Transplantation 2022; 36(10) doi: 10.1111/ctr.14656